Breckenridge Pharmaceutical Partners with Medichem Solutions to Expand Injectable Portfolio for Hospital Markets
Key Insights
Breckenridge Pharmaceutical (search) announced a strategic collaboration with Medichem Solutions (search) to expand its injectable business line with products for anesthesia, critical care, and emergency medicine.
The partnership strengthens Breckenridge's hospital channel presence as part of its strategic evolution into three distinct business lines: specialty, hospital, and retail.
Products will be manufactured at Medichem (search)'s new state-of-the-art sterile fill-and-finish facility in Asturias, Spain, supporting affordable generic medicine access.
Breckenridge Pharmaceutical (search) Inc., the U.S. subsidiary of Towa International (search), has announced a strategic collaboration with Medichem Solutions (search) S.L. to expand its injectable product portfolio across critical therapeutic areas including anesthesia, critical care, and emergency medicine. The partnership represents a significant step in Breckenridge's strategic evolution and commitment to the U.S. hospital channel.
Strategic Business Expansion
The collaboration strengthens Breckenridge Pharmaceutical (search)'s growing presence in the hospital channel and marks an important milestone in the company's strategic transformation into three distinct, patient-focused business lines: specialty, hospital, and retail. Brian Guy, President and Chief Commercial Officer of Breckenridge, emphasized the partnership's significance in building a diversified portfolio.
"This collaboration strengthens Breckenridge's growing presence in the hospital channel and represents another important milestone in our strategic evolution into three distinct, patient-focused business lines: specialty, hospital, and retail," Guy stated. "By partnering with Medichem Solutions (search), a trusted and experienced organization, we continue to build a diversified, patient-focused portfolio that supports healthcare providers with reliable, cost-effective treatment options."
Manufacturing Capabilities and Quality Focus
The injectable products covered under this collaboration will be among the first manufactured at Medichem (search)'s new, state-of-the-art facility in Asturias, Spain. This facility adds sterile fill-and-finish capabilities to Medichem Solutions (search)' business-to-business platform, enhancing the company's ability to support partners in expanding their portfolios of affordable, high-quality medicines.
Olga Urazova, Chief Commercial Officer of Medichem Solutions (search), expressed enthusiasm about the partnership: "Medichem Solutions is very excited to partner with Breckenridge on some of the first products to be manufactured at our new, state-of-the-art facility in Asturias, Spain. This site adds sterile fill-and-finish capabilities to Medichem (search)'s B2B platform and reinforces our purpose of supporting partners in expanding their portfolios of affordable, high-quality medicines."
Broader Patient Focus Strategy
Breckenridge's expanding hospital portfolio complements the company's broader focus on complex and underserved patient populations, including those in oncology, autoimmune, rare diseases, and pediatric care areas. The company aims to integrate these priorities across its specialty, hospital, and retail business lines through strategic partnerships to deliver meaningful therapeutic solutions that support patients throughout their treatment journey.
The collaboration reflects a shared dedication between both organizations to quality, reliability, and addressing critical patient needs across hospital settings. Both companies emphasize their commitment to delivering high-quality, affordable medicines upon which clinicians depend to treat patients.
Company Backgrounds
Breckenridge Pharmaceutical (search) Inc., based in New Jersey, serves as the U.S. subsidiary of Towa International (search), headquartered in Barcelona, Spain. The company partners with manufacturers nationwide and globally to bring quality, cost-effective generic pharmaceuticals to U.S. patients, focusing on customer service, on-time delivery, reliable supply, and quality manufacturing.
Medichem Solutions (search) S.L., a wholly owned subsidiary of Medichem (search), operates from Asturias, Spain. The parent company Medichem is a vertically integrated pharmaceutical company based in Barcelona, focused on developing and manufacturing high-quality active pharmaceutical ingredients and drug products for the global generics industry.